Member Info for itsallamess

BMH

You make some good point and then you devalue yourself with insults.. whats your problem?

This forum is for anyone to give their opinion.. right or wrong, its their opinion..

234k trade at £1.78 buy or sell?

Just to claify, was Timos last buy from the open market?

If so why if he felt a placing/fund raise was coming where his money would be better for faron and he would possibly get a lower price..

Well.done sax..

There is a nice 135k buy popped up!

Worth considering, would BP only be interested in bex if they are limited to MDS.. can't see them splitting the pie with a competitor.

So.either a full buy out now.. or will they seek funding to prove up bex for other cancers so shareholders get maximum value out of bex...?

Or as Abraham lincolnsaid, "Give me six hours to chop down a tree and I will spend the first four sharpening the axe,"

Just listened to the webinar..

I dont think they are looking at a total sell out of faron to big Pharma.

Around the 28 minute mark, Juhu talks about the greater benefits of bex and proving it up to for more cancers and shareholders benefiting from this..

I think they want to get a revenue MDS to making a revenue to pay for further research.

Added a few more..

Thanks all for your imput, been busy at work and still haven't listened to it yet.. will do tomorrow.

All sounds positive.. waiting for some cash to reach my bank from a T212 account so I can buy more via my II account.. see what happens Monday.

Over on the Finnish board someone mentioned a interview tomorrow on their TV..

Sorry for the confusion, I should have said Chairman of the nomination board..

However, he is on the inside and keeps buying so that should give us all confidence:)

Https://faron.com/investors/governance/board-committees/

Shareholders’ Nomination Board

The nomination committee considers succession planning for Directors and other senior executives in the course of its work, bearing in mind the challenges and opportunities facing the Company and the skills and expertise needed on the Board in the future, and makes recommendations to the Board concerning formulating plans for succession for both Executive and Non-Executive Directors and in particular for the key roles of Chairman and Chief Executive Officer.

The Shareholders’ Nomination Board prepares and presents proposals to the Annual General Meeting on the number, composition and remuneration of the members of the Board as well as the Chair of the Board of Directors.

Faron’s Shareholders’ Nomination Board consists of three members, which represent the Company’s shareholders. The Chair of Faron’s Board of Directors, Mr. Tuomo Pätsi, will serve as an expert in the Nomination Board without being a member.

As of 5 November 2024, the nomination committee comprises Timo Syrjälä representing himself as Chair and Erkka Kohonen, representing Varma Mutual Pension Insurance Company, and Joonas Haakana, representing UMO Capital, as the other members

Partnering is the first thing he mentions.. so is it cause he knows thats what the investors want to hear.. or is he sending a message to BP that their no.1 choice would be a partner, but there is other ways to raise funds so dont mess around too long!

Either way, we will find out soon..

Also.Timo isnt stupid.. it seems he can generate money to invest in Farn.. and as chairman of faron.. why would he buy more shares right now, if he thought the price would get lower soon on whatever news about funding is gonna come out soon.

Whenever there is a fundraise, the price set for shares is always a little lower than the current share price.. Timo know this so no.ppint buying now.. if indeed a fundraise was gonna happen..

Based on that, a partner in some forms seems to be on the cards..

A few big trades just showed up from yesterday.. buys or sells?

So assuming Timo has some insight knowledge.. it would be reasonable that if he is buying now, then buying in at a lower price anytime soon due to a placing is off the table for now.!

Prices us about £1 above current levels.. happy for that right now.. roll on a partnership!

https://www.redeye.se/research/1131338/faron-pharmaceuticals-updated-bexmab-data-from-esmo-2025-shows-further-improvements

Faron Pharmaceuticals

Overall, the updated BEXMAB data deepen our confidence in bexmarilimab’s differentiated mechanism and clinical value proposition. The consistent efficacy across subgroups, coupled with the newly established pharmacodynamic correlation, suggests that bexmarilimab could emerge as one of the most promising new agents in HR-MDS. The key focus now shifts to execution of the pivotal program and securing the financial and strategic partnerships required to advance the therapy toward approval. For now, we reiterate our base case valuation of EUR3.2 per share (bull: EUR7.5, bear: EUR1.2).

Https://www.proactiveinvestors.com/companies/news/1080665/faron-data-shows-stronger-response-to-bexmarilimab-in-high-risk-blood-cancer-trial-1080665.html?rel=scroll

A couple of days old, but still very encouraging for investors

Same here, another top up.. Follow the Timo!

Https://faron.videosync.fi/esmo-2025/register

Https://www.inderes.fi/analyst-comments/faronin-esmo-tiedote-taydensi-aiemmin-kerrottuja-paatuloksia

Https://faron.com/wp-content/uploads/2025/10/BEXMAB_ESMO2025-presentation_09OCT2025_FINAL.pdf